Home > Insider Trading > Filing (0000899243-21-049208)

Filing Details

Accession Number:: 0000899243-21-049208
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-12-21 18:35:42
Reporting Period:: 2021-12-17

Accepted Time:: 2021-12-21 18:35:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1261333	Docusign Inc.	DOCU	Services-Prepackaged Software (7372)	912183967

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1295402	T Enrique Salem	C/O Bain Capital Venture Investors, Llc 200 Clarendon Street Boston MA 02116		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-12-17	624,736	$0.00	37,764	No	4	J	Indirect	See footnotes
Common Stock	Disposition	2021-12-21	12,143	$147.82	25,621	No	4	S	Indirect	See footnotes
Common Stock	Disposition	2021-12-21	20,721	$148.59	4,900	No	4	S	Indirect	See footnotes
Common Stock	Disposition	2021-12-21	4,400	$149.57	500	No	4	S	Indirect	See footnotes
Common Stock	Disposition	2021-12-21	500	$150.50	0	No	4	S	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	J	Indirect	See footnotes
No	4	S	Indirect	See footnotes
No	4	S	Indirect	See footnotes
No	4	S	Indirect	See footnotes
No	4	S	Indirect	See footnotes

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	162,897	Direct

Footnotes

Represents shares of Common Stock held directly by BCIP Venture Associates ("BCIP Venture"), BCIP Venture Associates-B ("BCIP Venture-B"), BCIP Venture Associates II, L.P. ("BCIP Venture II"), BCIP Venture Associates II-B, L.P. ("BCIP Venture II-B"), Bain Capital Venture Fund 2014, L.P. ("BCV Fund 2014"), Bain Capital Venture Partners 2014, L.P. ("BCV Partners 2014"), Bain Capital Venture Coinvestment Fund, L.P. ("BCV Coinvest Fund") and Bain Capital Venture Coinvestment Partners, L.P. ("BCV Coinvest Partners" and, collectively, the "Bain Capital Venture Entities").
Bain Capital Venture Investors, LLC ("BCVI") is (i) the general partner of each of BCV Partners 2014, which is the general partner of BCV Fund 2014, and BCV Coinvest Partners, which is the general partner of BCV Coinvest Fund, and (ii) governs the investment strategy and decision-making process with respect to investments held by each of BCIP Venture, BCIP Venture-B, BCIP Venture II and BCIP Venture II-B. Mr. Salem is a member of the Executive Committee and a Managing Director of BCVI. By virtue of the relationships described in this footnote, Mr. Salem may be deemed to share voting and dispositive power with respect to all of the shares of Common Stock held by the Bain Capital Venture Entities. Mr. Salem disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
On December 17, 2021, certain of the Bain Capital Venture Entities distributed an aggregate of 624,736 shares of Common Stock to one or more partners in pro-rata in-kind distributions without consideration, including an aggregate of 12,790 shares of Common Stock that were distributed to Mr. Salem.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.20 to $148.19, inclusive. The reporting person undertakes to provide to DocuSign, Inc., any security holder of DocuSign, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) through (7) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.205 to $149.1925, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.2175 to $150.17, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.21 to $150.975, inclusive.
Includes 12,790 shares of Common Stock received in the distributions referred to in footnote (3) above.